Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML.
Batcha AMN, Buckup N, Bamopoulos SA, Jurinovic V, Rothenberg-Thurley M, Gittinger H, Ksienzyk B, Dufour A, Schneider S, Kontro M, Saad J, Heckman CA, Sauerland CM, Görlich D, Berdel WE, Wörmann B, Krug U, Braess J, Mansmann UR, Hiddemann W, Spiekermann K, Metzeler KH, Herold T
Research article (journal) | Peer reviewedDetails about the publication
Journal: Blood Advances
Volume: 7
Issue: 6
Page range: 1040-1044
Status: Published
Release year: 2023
Language in which the publication is written: English
Keywords: Clinical Trials and Observations; Myeloid Neoplasia
Authors from the University of Münster
| Berdel, Wolfgang Eduard | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
| Görlich, Dennis | Institute of Biostatistics and Clinical Research (IBKF) |
| Sauerland, Maria Cristina | Institute of Biostatistics and Clinical Research (IBKF) |